Lewis H. Titterton Jr., Anixa Biosciences stock purchase

Director, SEC Form 4, filed on October 26, 2026
$23,8408,000 shares, average $2.98
Transaction date
October 23, 2026
Shares held after
1,054,003Direct ownership
Change in holding
+0.76%From the transactions in the filing
Filing rows
1All open market

Price context

ANIX daily close, Apr 27 to October 26, 2026
$3.75$2.35
Daily close
Purchase
Trade average $2.98
Transaction price
$2.98Weighted average
Close on trade date
$2.99October 23, 2026
Latest close
$2.93October 26, 2026
Since the trade
−1.68%vs the trade average

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Purchase
Common stockDirect
8,000
$2.98
$23,840
1,054,003

Recent filings at Anixa Biosciences

Full history
PersonTransactionAmount or sharesDate
Amit KumarCEO
Purchase
$21,760
Michael CatelaniCFO
Purchase
$15,620
Amit KumarCEO
Purchase
$19,460
Arnold M. BaskiesDirector
Purchase
$13,800
Lewis H. Titterton Jr.Director
Purchase
$27,300
Amit KumarCEO
Purchase
$13,800
Amit KumarCEO
Purchase
$8,250
Amit KumarCEO
Purchase
$17,350